Dr. Nima Matin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17w735 Butterfield Rd Ste C, Oakbrook Terrace, IL 60181 Phone: 630-828-6978 Fax: 630-385-0122 |
Fatima Zahra Malik Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17w755 Butterfield Rd, Oakbrook Terrace, IL 60181 Phone: 630-785-6477 |
Dr. Kristina Lynn Kruskol, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17w675 Roosevelt Rd, Oakbrook Terrace, IL 60181 Phone: 630-620-2429 |
Dr. Jorge D Carrillo, PHARMD, MS, BCPS Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 1 Renaissance Blvd, Oakbrook Terrace, IL 60181 Phone: 630-792-5783 |
News Archive
China Biologic Products, Inc., one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, operating through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd. and its equity investment in Xi'an Huitian Blood Products Co., Ltd., today reported financial results for its first quarter ended March 31, 2010.
They're ba-ack! But in a new disease-fighting role. Viruses that infect and kill bacteria - used to treat infections in the pre-antibiotic era a century ago and in the former Soviet Union today - may have a new role in preventing formation of the sticky "biofilms" of bacteria responsible for infections on implanted medical devices.
A gene mutation associated with a rare sleep disorder surprisingly also contributes to debilitating migraines, a new discovery that could change the treatment of migraines by allowing development of drugs specifically designed to treat the chronic headaches.
​Scientists have discovered that Crohn's disease, the inflammatory bowel disorder, can originate from specialised intestinal cell type called Paneth cells. As such, they propose that small intestinal Crohn's disease might be a specific disorder of this cell type, providing a possible new target for treatments.
Arena Pharmaceuticals, Inc. today announced that Ildong Pharmaceutical Co., Ltd., has informed Arena that the Ministry of Food and Drug Safety has approved BELVIQ (lorcaserin HCl) for marketing for weight management in South Korea. Ildong will market and distribute BELVIQ in South Korea under its marketing and supply agreement with Arena's wholly owned subsidiary, Arena Pharmaceuticals GmbH, or Arena GmbH.
› Verified 6 days ago